Stay updated on Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Locations section now includes numerous new study sites across multiple countries and regions (e.g., Florida, Kentucky, Brussels, Tokyo, Buenos Aires, etc.), with several prior sites removed, altering where participants can enroll.
    Difference
    2%
    Check dated 2025-12-18T20:51:57.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a 2025 Blood Advances publication entry related to risk stratification of low-dose cytarabine with venetoclax. Updated the page revision to v3.3.2; the older PubMed publication note (v3.2.0) was removed.
    Difference
    0.1%
    Check dated 2025-11-27T03:00:50.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The government funding operating-status notice has been removed from the page, eliminating a site-wide alert about potential delays and updates. The study details (title, interventions, endpoints, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-19T22:12:47.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The new screenshot shows only administrative metadata updates (e.g., last update timestamp); core study content remains unchanged—To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-29T10:09:18.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page now shows an updated operating-status notice, new future dates, and a new revision/version (v3.2.0), while removing several past dates and the previous revision (v3.1.0), indicating an updated status and timeline information.
    Difference
    1%
    Check dated 2025-10-07T23:21:00.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Incremental version update: replacing the old revision tag v3.0.2 with a new v3.1.0.
    Difference
    0.0%
    Check dated 2025-09-30T02:44:11.000Z thumbnail image

Stay in the know with updates to Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.